↓ Skip to main content

Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies

Overview of attention for article published in Nature Genetics, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
twitter
115 X users

Citations

dimensions_citation
180 Dimensions

Readers on

mendeley
221 Mendeley